- Home
- Publications
- Publication Search
- Publication Details
Title
Innovating Clinical Trials for Amyotrophic Lateral Sclerosis
Authors
Keywords
-
Journal
NEUROLOGY
Volume 97, Issue 11, Pages 528-536
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-07-28
DOI
10.1212/wnl.0000000000012545
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic models for amyotrophic lateral sclerosis: a systematic review
- (2021) Lu Xu et al. JOURNAL OF NEUROLOGY
- Disease-modifying therapies in amyotrophic lateral sclerosis
- (2020) Adriano Chiò et al. NEUROPHARMACOLOGY
- TRICALS: creating a highway toward a cure
- (2020) Ruben P.A. van Eijk et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials
- (2019) Ruben P.A. van Eijk et al. NEUROLOGY
- Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials
- (2019) Leonard H. van den Berg et al. NEUROLOGY
- Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trials
- (2019) Ruben P A van Eijk et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- ALS drug development guidances and trial guidelines
- (2019) Jinsy A. Andrews et al. NEUROLOGY
- Increasing the efficiency of clinical trials in neurodegenerative disorders using group sequential trial designs
- (2018) Ruben P.A. van Eijk et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model
- (2018) Henk-Jan Westeneng et al. LANCET NEUROLOGY
- Comparing methods to combine functional loss and mortality in clinical trials for amyotrophic lateral sclerosis
- (2018) Ruben P.A. van Eijk et al. Clinical Epidemiology
- Improved stratification of ALS clinical trials using predicted survival
- (2018) James D. Berry et al. Annals of Clinical and Translational Neurology
- Power Calculations for Clinical Trials in Alzheimer's Disease
- (2018) M. Colin Ard et al. JOURNAL OF ALZHEIMERS DISEASE
- The changing picture of amyotrophic lateral sclerosis: lessons from European registers
- (2017) Orla Hardiman et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Edaravone: a new treatment for ALS on the horizon?
- (2017) Orla Hardiman et al. LANCET NEUROLOGY
- Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2017) Vincent Meininger et al. LANCET NEUROLOGY
- Information time scales for interim analyses of randomized clinical trials
- (2016) Boris Freidlin et al. Clinical Trials
- Some Issues of Sample Size Calculation for Time-to-Event Endpoints Using the Freedman and Schoenfeld Formulas
- (2015) Ulrich R. Abel et al. Journal of Biopharmaceutical Statistics
- Sample Size Calculation: Inaccurate A Priori Assumptions for Nuisance Parameters Can Greatly Affect the Power of a Randomized Controlled Trial
- (2015) Elsa Tavernier et al. PLoS One
- Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?
- (2014) Hiroshi Mitsumoto et al. LANCET NEUROLOGY
- Sample size calculations in pediatric clinical trials conducted in an ICU: a systematic review
- (2014) Stavros Nikolakopoulos et al. Trials
- The risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studies
- (2014) Brennan C Kahan et al. Trials
- Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial
- (2013) Merit E Cudkowicz et al. LANCET NEUROLOGY
- Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
- (2013) LANCET NEUROLOGY
- Analysis of start-up, retention, and adherence in ALS clinical trials
- (2013) N. Atassi et al. NEUROLOGY
- The Combined Assessment of Function and Survival (CAFS): A new endpoint for ALS clinical trials
- (2013) James D. Berry et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Lithium lacks effect on survival in amyotrophic lateral sclerosis: a phase IIb randomised sequential trial
- (2012) Esther Verstraete et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- ALS clinical trials: Do enrolled patients accurately represent the ALS population?
- (2011) A. Chio et al. NEUROLOGY
- Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis
- (2009) Sanne Piepers et al. ANNALS OF NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started